Literature DB >> 11352867

Successful transformation of cryopreserved lymphocytes: a resource for epidemiological studies.

J C Beck1, C M Beiswanger, E M John, E Satariano, D West.   

Abstract

Mesh：

Year:  2001        PMID： 11352867

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN： 1055-9965            Impact factor:   4.254


× No keyword cloud information.
  24 in total

1.  Establishment of stably EBV-transformed cell lines from residual clinical blood samples for use in performance evaluation and quality assurance in molecular genetic testing.

Authors:  Susan H Bernacki; Ana K Stankovic; Laurina O Williams; Jeanne C Beck; James E Herndon; Karen Snow-Bailey; Thomas W Prior; Karla J Matteson; Linda M Wasserman; Eugene C Cole; Timothy T Stenzel
Journal:  J Mol Diagn       Date:  2003-11       Impact factor: 5.568

2.  Population differences in the rate of proliferation of international HapMap cell lines.

Authors:  Amy L Stark; Wei Zhang; Tong Zhou; Peter H O'Donnell; Christine M Beiswanger; R Stephanie Huang; Nancy J Cox; M Eileen Dolan
Journal:  Am J Hum Genet       Date:  2010-11-25       Impact factor: 11.025

3.  High-potentiality preliminary selection criteria and transformation time-dependent factors analysis for establishing Epstein-Barr virus transformed human lymphoblastoid cell lines.

Authors:  I-C Chang; J-Y Wu; H-I Lu; H-W Ko; J-L Kuo; C-Y Wang; P-S Shen; S-M Hwang
Journal:  Cell Prolif       Date:  2006-12       Impact factor: 6.831

4.  Development of genomic reference materials for cystic fibrosis genetic testing.

Authors:  Victoria M Pratt; Michele Caggana; Christina Bridges; Arlene M Buller; Lisa DiAntonio; W Edward Highsmith; Leonard M Holtegaard; Kasinathan Muralidharan; Elizabeth M Rohlfs; Jack Tarleton; Lorraine Toji; Shannon D Barker; Lisa V Kalman
Journal:  J Mol Diagn       Date:  2009-04-09       Impact factor: 5.568

5.  Double-strand breaks repair in lymphoblastoid cell lines from sisters discordant for breast cancer from the New York site of the BCFR.

Authors:  Nicola Machella; Mary Beth Terry; Jennifer Zipprich; Irina Gurvich; Yuyan Liao; Ruby T Senie; David O Kennedy; Regina M Santella
Journal:  Carcinogenesis       Date:  2008-06-19       Impact factor: 4.944

6.  Development and characterization of reference materials for MTHFR, SERPINA1, RET, BRCA1, and BRCA2 genetic testing.

Authors:  Shannon D Barker; Sherri Bale; Jessica Booker; Arlene Buller; Soma Das; Kenneth Friedman; Andrew K Godwin; Wayne W Grody; Edward Highsmith; Jeffery A Kant; Elaine Lyon; Rong Mao; Kristin G Monaghan; Deborah A Payne; Victoria M Pratt; Iris Schrijver; Antony E Shrimpton; Elaine Spector; Milhan Telatar; Lorraine Toji; Karen Weck; Barbara Zehnbauer; Lisa V Kalman
Journal:  J Mol Diagn       Date:  2009-09-18       Impact factor: 5.568

7.  Development of genomic DNA reference materials for genetic testing of disorders common in people of ashkenazi jewish descent.

Authors:  Lisa Kalman; Jean Amos Wilson; Arlene Buller; John Dixon; Lisa Edelmann; Louis Geller; William Edward Highsmith; Leonard Holtegaard; Ruth Kornreich; Elizabeth M Rohlfs; Toby L Payeur; Tina Sellers; Lorraine Toji; Kasinathan Muralidharan
Journal:  J Mol Diagn       Date:  2009-10-08       Impact factor: 5.568

8.  A Simple Red Blood Cell Lysis Method for the Establishment of B Lymphoblastoid Cell Lines.

Authors:  Xi Liu; Chongfeng Xu; Ziyuan Duan
Journal:  J Vis Exp       Date:  2017-01-14       Impact factor: 1.355

9.  Capacity of robot handling for Epstein-Barr virus transformation.

Authors:  I-C Chang; H-W Ko; S-M Hwang
Journal:  Cell Prolif       Date:  2009-02       Impact factor: 6.831

10.  XRCC1 polymorphisms and breast cancer risk from the New York Site of the Breast Cancer Family Registry: A family-based case-control study.

Authors:  Jennifer Zipprich; Mary Beth Terry; Paul Brandt-Rauf; Greg A Freyer; Yuyan Liao; Meenakshi Agrawal; Irina Gurvich; Ruby Senie; Regina M Santella
Journal:  J Carcinog       Date:  2010-04-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.